GLUE - Monte Rosa Therapeutics, Inc. -  [ ]

Ticker Details
Monte Rosa Therapeutics, Inc.
IPO Date: June 24, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.59B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 4.06%
Avg Daily Range (30 D): $0.48 | 2.49%
Avg Daily Range (90 D): $0.49 | 2.59%
Institutional Daily Volume
Avg Daily Volume: .49M
Avg Daily Volume (30 D): .63M
Avg Daily Volume (90 D): .83M
Trade Size
Avg Trade Size (Sh.): 86
Avg Trade Size (Sh.) (30 D): 53
Avg Trade Size (Sh.) (90 D): 60
Institutional Trades
Total Institutional Trades: 514
Avg Institutional Trade: $2.4M
Avg Institutional Trade (30 D): $1.84M
Avg Institutional Trade (90 D): $2.25M
Avg Institutional Trade Volume: .2M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.7M
Avg Closing Trade (30 D): $2.4M
Avg Closing Trade (90 D): $2.98M
Avg Closing Volume: 184.57K
 
News
May 20, 2026 @ 11:00 AM
Monte Rosa Therapeutics to Participate in Upcoming...
Source: Not Specified
Feb 6, 2026 @ 5:16 PM
3 High-Risk Stocks That Soared in 2025 But Can Sti...
Source: Chris Markoch
Jan 9, 2026 @ 3:49 AM
Monte Rosa Therapeutics Announces Pricing of $300 ...
Source: Na
Nov 8, 2025 @ 4:30 PM
Monte Rosa Therapeutics Presents Preclinical Data ...
Source: Monte Rosa Therapeutics
Nov 3, 2025 @ 12:00 PM
Monte Rosa Therapeutics to Participate in Upcoming...
Source: Monte Rosa Therapeutics
Financials
  TTM Q1 2026 Q3 2025
Basic EPS
Diluted EPS
Revenue $4.21M $12.77M
Gross Profit
Net Income / Loss $-129.99M $-44.5M $-27.08M
Operating Income / Loss $-50.03M $-32.98M
Cost of Revenue
Net Cash Flow $29.97M $138.91M
PE Ratio